DC Investments Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
DC Investments Management's MRNA Position: Q2 2026 in Review
DC Investments Management held its Moderna (MRNA) position steady in Q2 2026 at 68,624 shares worth $4.81M. The position accounts for 1.64% of the portfolio, ranked #6.
DC Investments Management first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- DC Investments Management held 68,624 shares of Moderna worth $4.81M as of Q2 2026.
- DC Investments Management left its Moderna share count unchanged in Q2 2026.
- Moderna made up 1.64% of DC Investments Management's portfolio in Q2 2026, its #6 holding.
- DC Investments Management first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on DC Investments Management's 13F filing for Q2 2026, filed 14 Aug 2026.